Helping a good friend try and balance her pain meds after surgery last week, and writing Monday’s post got me thinking. What are my favorite pain killers? My drugs of choice?
Talk about conflicting data! According to a number of researchers, the amino acid, L-glutamine, may be bad for multiple myeloma patients. Yet taken in large enough doses it clearly helps many control their peripheral neuropathy.
I’m constantly harping on how important it is to be an informed patient. I referred to it several times this weekend: “Some patients can’t even name the chemotherapy that they’re on! That’s fine, as long as nothing goes wrong.”
Following Friday’s post about the release of important clinical trial data at the American Society of Clinical Oncology (ASCO) and European Hematology Association (EHA) meetings in June, Joe asked this:
Danny Parker wrote a cautionary series of posts about why and how to avoid shingles last week. He touched on other infection risks, but I would like to share some specifics about it.
Here’s Part Two of Danny Parker’s expose’ about ways to avoid the shingles virus and other infections:
We haven’t heard from lifestyle columnist and myeloma survivor, Danny Parker, since last year. He’s been busy; Danny works as an engineer and spends much of his time in Europe. But that isn’t the only reason.
From what may be possible in the future to an easy way to temporarily overcome myeloma drug resistance now.
I’m a mess. Despite being my week off therapy, I’m having a heck of a time focusing. And a more painful form of peripheral neuropathy recently emerged from a long, medicated nap.
I’ve recently received a lot of constructive criticism from readers that feel my doctors should reduce my weekly dexamethasone dose–or eliminate it altogether.
What a fascinating, enlightening conversation! An hour long broadcast wasn’t enough time to cover Cannabis for Cancer.
Triphase Accelerator Corp. announced today that it’s new proteasome inhibitor, marizomib, has been granted orphan drug designation by the FDA’s Office of Orphan Products Development for the treatment of multiple myeloma.
Dexamethasone helps other myeloma therapies work better. And it’s cheap. Anyone ever have anything else good to say about dex? Surprisingly, YES!
Dexamethasone. When compared to novel therapy agents like Revlimid and Velcade, it’s almost an afterthought. But using it with most any myeloma therapy enhances effectiveness by 30 – 40%.
Last week I shared a number of useful suggestions made on-air by my special guest, Dr. Donald Abrahms, on our monthly Cure Talk broadcast. Here are some more:
This news isn’t new, it’s just news to me: taking 20 mg of piperine enhances curcumin’s bio availability by up to 2000%. 2000%!
I was honored to be selected to host an on-air Cure Talk interview with oncologist and integrative medicine specialist, Dr. Donald Abrams Friday evening. It’s a must listen for anyone concerned about nutrition and it’s impact on cancer.
Marijuana an anti-myeloma drug? Researchers have been fiddling with using cannabidiol to help destroy myeloma cells for years. Just having some fun with this. Here’s a report from the British Isles with an update:
Sometimes important findings at ASH are lost in the rush to cover the hot, new therapies. This data about the optimum amount of Velcade to take over time is significant.
Covering technical, four hour events like Friday’s pre-ASH symposium can be challenging; even grueling. My peripheral neuropathy and back pain makes it hard to sit still and type on the fly. And this year I’m trying to tweet simultaneously while blogging.